Overview

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Status:
RECRUITING

Trial end date:
2030-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.

Phase:

PHASE3

Details

Lead Sponsor:

UCB Biopharma SRL

Treatments:

brivaracetam